Prospective, randomized, double-blind study of high-dose aprotinin in pediatric cardiac operations

Annals of Thoracic Surgery

Volumn 63, Issue 2, 1997, Pages 497-503

  Davies, Michael J ^b   Allen, Alison ^b   Kort, Henry ^b   Weerasena, Nihal A ^b   Rocco, Domenico ^b   Paul, Claire L ^b   Hunt, Beverley J ^b   Elliott, Martin J ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; BETA THROMBOGLOBULIN; PLACEBO;

ADOLESCENT; ARTICLE; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FIBRINOLYSIS; HEART SURGERY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PEDIATRIC SURGERY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE;

APROTININ; BETA-THROMBOGLOBULIN; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; FIBRINOLYSIS; HEART DEFECTS, CONGENITAL; HEMOSTATICS; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES;

EID: 0031057055     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)01031-4     Document Type: Article

References (20)

1. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effects of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987;2:1289-91.
2. Van Oeveren W, Jansen NJG, Bidstrup BP, et al. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg 1987;44:640-5.
3. Bidstrup BP, Royston D, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 1989;97: 364-72.
4. Havel M, Teufelsbauer H, Knobl P, et al. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation. J Thorac Cardiovasc Surg 1991;101:968-72.
5. Blauhut B, Gross C, Necek S, Doran JE, Spath P, Lundsgaard-Hansen P. Effects of high dose aprotinin on blood loss, platelet function, fibrinolysis, complement and renal function after cardiopulmonary bypass. J Cardiovasc Surg 1991; 101:958-67.
6. Papov-Cenic S, Urban AE, Noe G. Studies on the cause of bleeding during and after surgery with a heart-lung machine in children with cyanotic and acyanotic congenital cardiac defects and their prophylactic treatment. In: Role of chemical mediators in the pathophysiology of acute illness and injury. New York: Raven Press, 1982:229-42.
7. Herynkopf F, Lucchese F, Pereira E, Kalil R, Prates P, Nesralla IA. Aprotinin in children undergoing correction of congenital heart defects. A double-blind pilot study. J Thorac Cardiovasc Surg 1994;108:517-21.
8. Tanaka K, Takao M, Yada I, Yusa H, Kusagawa M, Deguchi K. Alterations in coagulation and fibrinolysis associated with cardio-pulmonary bypass during open-heart surgery. J Cardiothorac Vase Anesth 1989;3:181-8.
9. Hunt BJ, Yacoub M. Aprotinin and cardiac surgery: reduces perioperative blood loss. Br Med J 1991;303:660-1.
10. Hunt BJ, Segal H, Yacoub M. Aprotinin and heparin monitoring during cardio-pulmonary bypass. Circulation 1992;86 (Suppl 2):410-2.
11. Francis JL, Howard C. The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin. Blood Coagul Fibrinolysis 1993;4:35-40.
12. Jaquiss RD, Huddleston CB, Spray TL. Use of aprotinin in pediatric lung transplantation. J Heart Lung Transplant 1995; 14:302-7.
13. Boldt J, Knothe C, Zickmann B, Wege N, Dapper F, Hempelmann G. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss. J Thorac Cardiovasc Surg 1993;105:705-11.
14. Davis R, Whittington R. Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery. Drugs 1995;49:954-83.
15. Elliott MJ, Allen A. Aprotinin in paediatric cardiac surgery. Perfusion 1990;5(Suppl):73-6.
16. Bjorkhem G, Lundstrom NR. Echocardiographic studies of children operated on for congenital heart disease; evaluation in the immediate postoperative period. Europ J Cardiol 1979; 10:429-51.
17. Dietrich W, Henze R, Barankay A, Niekau E, Sebening F, Richter JA. High-dose aprotinin application reduces homologous blood requirement in cardiac surgery. J Cardiothorac Anesth 1989;3(Suppl 1):79.
18. Hunt BJ, Yacoub M. Aprotinin and cardiac surgery [Letter; Comment]. Br Med J 1991;303:1401.
19. Orchard NA, Goodchild DF, Prentice CRN, et al. Aprotinin reduces cardiopulmonary bypass induced blood loss and inhibits fibrinolysis without influencing platelets. Br J Haematol 1993;85:533-41.
20. Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs 1985;29:236-61.